Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

NCT01773122 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01773122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01773122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris
Lead sponsor
Allergan
Phase
Phase 1
Overall status
Completed
Start date
January 21, 2013
Completion date
May 5, 2013
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris